您的位置: 首页 > 农业专利 > 详情页

Oligonucleotides matching COL7A1 exon 73 for epidermolysis bullosa therapy
专利权人:
ProQR Therapeutics II B.V.
发明人:
Haisma, Elisabeth Marlene,Potman, Marko,Beumer, Wouter,Brinks, Vera
申请号:
AU2016231067
公开号:
AU2016231067A1
申请日:
2016.03.11
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
Antisense oligonucleotides capable of preventing or reducing exon 73 inclusion into the human COL7A mRNA are characterized in various ways: (a) the oligonucleotide's sequence includes at most two CpG sequences; (b) the oligonucleotide has a length of no more than 24 nucleotides; (c) the oligonucleotide is capable of annealing to the (SRp40/SC35 binding / ESE) element in exon73. These oligonucleotides can usefully be oligoribonucleotides with modified internucleosidic linkages e.g. phosphorothioate linkages.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充